AbbVie is a global pharmaceutical company headquartered in North Chicago, Illinois, United States. The company was founded in 2013 as a spin-off from Abbott Laboratories, and it specializes in the development and commercialization of innovative therapies for various diseases, including immunology, oncology, neuroscience, and virology. AbbVie is a leading player in the Large Pharma sector, with a strong portfolio of drugs and a global presence in over 175 countries.

As a large corporation, AbbVie recognizes the importance of decarbonization and reducing its carbon footprint to mitigate the impact of climate change. The company has set ambitious sustainability goals to reduce its greenhouse gas emissions, energy consumption, and water usage. AbbVie aims to achieve carbon neutrality by 2050 and has committed to reducing its absolute Scope 1 and 2 emissions by 30% by 2030, using 2015 as a baseline.

One of the key strategies that AbbVie is implementing to achieve its sustainability goals is corporate energy management. The company is investing in energy-efficient technologies, such as LED lighting, HVAC systems, and building automation, to reduce its energy consumption and costs. AbbVie has also implemented a global energy management system that tracks and analyzes energy use across its facilities, identifies areas for improvement, and sets targets for energy reduction.

Another important initiative that AbbVie is undertaking to decarbonize its operations is the use of corporate power purchase agreements (PPAs) for renewable energy. PPAs are long-term contracts between a company and a renewable energy provider, where the company agrees to purchase a specified amount of renewable energy at a fixed price over a period of time. AbbVie has signed several PPAs for wind and solar energy, which will provide the company with a reliable and cost-effective source of renewable energy and help it to achieve its sustainability goals.

One example of AbbVie's commitment to renewable energy is its partnership with Invenergy, a leading renewable energy developer. AbbVie has signed a 10-year PPA with Invenergy to purchase 100 MW of wind energy from the Santa Rita East Wind Farm in Texas. The wind farm will provide AbbVie with enough renewable energy to power its entire US operations, including its research and development facilities, manufacturing plants, and offices. The PPA will also help AbbVie to reduce its carbon footprint by over 150,000 metric tons of CO2e per year, which is equivalent to taking 32,000 cars off the road.

AbbVie is also investing in on-site renewable energy generation, such as solar panels and cogeneration systems, to further reduce its reliance on fossil fuels and grid electricity. The company has installed over 4,000 solar panels at its manufacturing facility in Puerto Rico, which generate over 1.5 million kWh of renewable energy per year. AbbVie has also implemented a cogeneration system at its manufacturing plant in Ireland, which uses natural gas to generate electricity and heat, reducing its energy costs and carbon emissions.

In addition to its efforts to decarbonize its operations, AbbVie is also committed to sustainable water management. The company has set a goal to reduce its water usage by 50% by 2030, using 2015 as a baseline. AbbVie is implementing water conservation measures, such as rainwater harvesting, wastewater treatment, and water reuse, to reduce its water consumption and improve its water efficiency.

AbbVie's sustainability efforts have been recognized by several organizations and industry groups. The company has been included in the Dow Jones Sustainability Index for six consecutive years and has been named one of the World's Most Ethical Companies by the Ethisphere Institute for nine consecutive years. AbbVie has also received several awards for its renewable energy and sustainability initiatives, including the EPA Green Power Leadership Award and the Corporate Renewable Energy Procurement Award.

In conclusion, AbbVie is a leading pharmaceutical company that is committed to decarbonizing its operations and reducing its carbon footprint. The company is implementing a range of sustainability initiatives, including corporate energy management, corporate PPAs for renewable energy, and on-site renewable energy generation, to achieve its sustainability goals. AbbVie's efforts to reduce its greenhouse gas emissions, energy consumption, and water usage have been recognized by industry groups and demonstrate its commitment to sustainability and corporate responsibility.